Percepta Bronchial Genomic Classifier, a new diagnostic test from Veracyte Inc, can assess a person's risk for lung cancer.
Practice Fusion has announced the launch of two EHR initiatives, including Population Health Management program for patient populations with respiratory conditions.
Swiss drugmaker Novartis said European health regulators have approved its ALK inhibitor Zykadia (ceritinib) for advanced lung cancer.
The US FDA has approved the antibiotic moxifloxacin (Avelox) to treat septicemic and pneumonic plague.
The European Commission has granted orphan medicinal product designation to AIT-CF, a cystic fibrosis treatment from Advanced Inhalation Therapies Ltd.
ResMed has launched its Lumis series of noninvasive ventilation devices in select European markets, with a global rollout planned in additional regions throughout 2015 and early 2016.
Nonin Medical has announced a partnership with IDEAL Life, a Toronto-based provider of remote health management solutions.
B&B Medical Technologies has received ISO 13485 Certification and Health Canada Medical Device Licenses to sell the B&B Bubbler and HOPE Nebulizer into the Canadian market.
GlaxoSmithKline (GSK) and Theravance, Inc, have announced that Breo Ellipta has been approved by the Food and Drug Administration (FDA) for the once-daily treatment of asthma in patients ages 18 years and older.
Current bubble CPAP products available on the market enable respiratory therapists to deliver vital care to newborns and infants.
3B Medical Inc has received FDA 510(k) clearance for its new Luna Positive Airway Pressure (PAP) device platform, according to a company announcement.
Breethe Inc has obtained exclusive rights to develop a wearable, portable blood pump oxygenator that will function as an artificial lung system for patients suffering from cardiopulmonary collapse and respiratory failure.
Canadian researchers have created a portable tool to predict avian flu outbreaks on farms.
Designed and manufactured in the USA, the Drive Pure O2 stationary concentrator is available in both oxygen sensing and non-oxygen sensing units.
Philips Respironics' Pico nasal mask is now available in the United States for the treatment of obstructive sleep apnea (OSA), according to a company announcement.
MedImmune has received fast track designation from the FDA for the development of MEDI8897, which is being investigated for use in infants and young children with RSV.
A Lung Disease News report discusses the new wearable devices designed to help manage cardiovascular and respiratory diseases.
The FDA has released enhanced recommendations on the production and disinfection of reusable medical devices, according to a press release.
GlaxoSmithKline has received approval from the Japanese Ministry of Health, Labour and Welfare for Encruse Ellipta to treat COPD. The drug has already been approved in the US and Canada under the trade name Incruse Ellipta.
Nihon Kohden has procured a group purchasing agreement for physiological monitoring with Premier Inc, a leading healthcare improvement company representing 3,400 US hospitals and 110,000 other providers.